QHP Capital has announced the appointment of Owen Murray as the new Chief Executive Officer for the recently combined entities of Bend Bioscience, CoreRx, and Societal. Murray, who most recently served as CEO of Aprecia Pharmaceutical, brings over 25 years
Pharmaceutical company CoreRx has completed its acquisition of Societal CDMO. The acquisition was achieved through a tender offer to purchase all issued and outstanding shares of Societal CDMO at a price of $1.10 per share. The tender offer expired as scheduled on April
In order to expand its capabilities, CoreRx, Inc. has announced a definitive agreement to acquire Societal CDMO, Inc. (NASDAQ: SCTL), a contract development and manufacturing organisation (CDMO) known for tackling complex formulation and manufacturing challenges. The transaction is expected to close early in
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
